Tag: Shape Memory Medical
Shape Memory Medical announces first European enrolment in AAA-SHAPE pivotal trial
Shape Memory Medical today announced the first European enrolment in the AAA-SHAPE pivotal trial, the company’s prospective, multicentre, randomised, open-label trial to determine the...
EMBO-PMS data reveal a variety of peripheral vascular applications with shape...
This advertorial is sponsored by Shape Memory Medical.
A wide variety of vessels treated with no device-related adverse events is a key recent finding to...
Shape Memory Medical announces first patient treated in the AAA-SHAPE randomised...
Shape Memory Medical recently announced that the first patient has been treated in the AAA-SHAPE pivotal trial.
AAA-SHAPE (Abdominal aortic aneurysm sac healing and prevention...
Active sac management represents “step forward” for EVAR
"Despite significant technological improvements since its inception, endovascular repair of abdominal aortic aneurysms (AAAs) is still associated with some of the same problems we...
Shape Memory Medical announces sublicense of intellectual property
Shape Memory Medical announced this week that it has entered into a sublicense agreement with a strategic global medical device company.
Under the agreement,...
One-year results from AAA-SHAPE trial to be presented at VEITH 2023
Shape Memory Medical, developer of custom shape memory polymers for endovascular markets, announced that one-year data from the AAA-SHAPE safety trial will be presented...
Vascular News’ top 10 most popular stories of September 2023
Discussions on the role of aritifical intelligence in the vascular field and emerging deep venous valve technologies caught readers' attention in September.
1. Humacyte announces...
Shape Memory Medical receives US FDA IDE approval to initiate head-to-head...
Shape Memory Medical recently announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) for the company to begin...
Shape memory polymer: “Another step down the road” toward active aneurysm...
“There is an increasing awareness that we need to get aneurysm sacs to regress after endovascular aneurysm repair ,” Andrew Holden (Auckland, New Zealand)...
Shape Memory Medical announces publication of study results
Shape Memory Medical has announced the publication of results from the company’s prospective, open-label, single-arm, safety study of the Impede embolisation plug in peripheral...
Shape Memory Medical announces first patient treated in EMBO postmarket surveillance...
Shape Memory Medical has announced the first patient treated in Germany as part of the EMBO postmarket surveillance registry (EMBO-PMS), the company’s prospective, multicentre...
Shape Memory Medical completes enrolment in the AAA-SHAPE early feasibility study
Shape Memory Medical has announced the completion of patient enrolment in AAA-SHAPE, the company’s prospective, multicentre early feasibility safety study of the Impede-FX RapidFill...
Shape Memory Polymer addresses an “unmet need” for EVAR
Andrew Holden (Auckland, New Zealand) and Michel Reijnen (Arnhem, The Netherlands) discuss Shape Memory Polymer (Shape Memory Medical)—a porous scaffold that, according to Holden,...
Shape Memory Medical celebrates treatment of 1,500th patient
Shape Memory Medical announced today that its 1,500th patient has been treated, marking a significant milestone for the company’s portfolio of shape memory polymer...
“Promising technology”: An interventional radiologist’s perspective on the benefits of shape...
This advertorial is sponsored by Shape Memory Medical.
Smart Polymer is a new shape memory polymer technology, available to endovascular specialists, that is incorporated into...
Stable and reliable: A vascular surgeon’s perspective on the benefits of...
This advertorial is sponsored by Shape Memory Medical.
Smart Polymer is a new shape memory polymer technology, available to endovascular specialists, that is incorporated into...
First patient enrolled in Shape Memory Medical’s AAA-SHAPE Netherlands study
Shape Memory Medical has announced the initiation of AAA-SHAPE Netherlands, the company’s prospective, multicentre early feasibility study of the Impede-FX RapidFill device when used...
Shape Memory Medical receives PMDA approval for the Impede-FX embolisation plug
Shape Memory Medical recently announced that it has received approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) to market its Impede-FX embolisation...
